More than ever, state-of-the-art-technologies provide the fulcrum of discovery for all facets of the continuum of science from the bench through clinical and translational studies and ultimately to improvements in human health. In today’s post-genomic era, technological resources and services increasingly define the common intersection between basic, clinical and translational science. For example, in the study of the population genetics of dyslipidemia, gene chip array technology essentially “sets the table” for the basic science geneticist, the university-based population scientist, and the community-based clinical investigator.

In this era of team science, technology, then, has the potential of being the flashpoint for formation of the

transdisciplinary teams rather than being the “possession” of individual or small groups of investigators working in the isolation of disease-focused departments and divisions. Therefore, the overall goal of this key function is to transform UK’s existing translational technology infrastructure to one that promotes team science rather than defines traditional silos.